Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Status Completed

Clinical Trial Summary

The overall goal of this study was to evaluate the comparative safety and effectiveness of rivaroxaban vs. vitamin K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) across risk profiles and comorbidities that reflect everyday clinical practice.

The primary objective in this study was to evaluate the combined end point of stroke or systemic embolism (SSE), and major bleeding in NVAF patients treated with rivaroxaban vs. VKA.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03374540
Study type	Observational
Source	Bayer
Contact
Status	Completed
Phase
Start date	December 1, 2017
Completion date	August 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04586972` - Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
Completed	`NCT02007655` - Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
Completed	`NCT02674594` - Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US	N/A
Recruiting	`NCT04494347` - Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)	N/A
Not yet recruiting	`NCT04942873` - The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
Recruiting	`NCT05731882` - First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder	N/A
Completed	`NCT01885598` - Eliquis Regulatory Post Marketing Surveillance	N/A
Completed	`NCT02919982` - Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
Completed	`NCT00684307` - Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation	Phase 2
Recruiting	`NCT04073316` - AntiCoagulants and COGnition	Phase 4
Recruiting	`NCT05715658` - Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects	N/A